Stockreport

Assessing Monte Rosa Therapeutics (GLUE) Valuation After MRT-2359 Data Update And New Public Offering [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF Clinical update and financing reshape Monte Rosa Therapeutics (GLUE) story Monte Rosa Therapeutics (GLUE) is back in focus after updated Phase 1/2 data for MRT-2359 i [Read more]